Bioventus Historical Cash Flow
| BVS Stock | USD 12.29 0.02 0.16% |
Analysis of Bioventus cash flow over time is an excellent tool to project Bioventus future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 2.6 M or Free Cash Flow of 15.1 M as it is a great indicator of Bioventus ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Bioventus latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bioventus is a good buy for the upcoming year.
Bioventus |
About Bioventus Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Bioventus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Bioventus's non-liquid assets can be easily converted into cash.
Bioventus Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Bioventus to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Bioventus operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Bioventus' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Bioventus current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioventus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.At this time, Bioventus' Dividends Paid is comparatively stable compared to the past year. Change To Netincome is likely to gain to about 18.1 M in 2024, whereas Stock Based Compensation is likely to drop slightly above 2.6 M in 2024.
| 2020 | 2021 | 2023 | 2024 (projected) | Change To Liabilities | 20.5M | 18.2M | 20.9M | 13.8M | Change To Netincome | 18.3M | 11.9M | 10.7M | 18.1M |
Bioventus cash flow statement Correlations
Click cells to compare fundamentals
Bioventus Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bioventus cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.4M) | (528K) | 3.2M | (18.6M) | (6.0M) | (5.7M) | |
| Change In Cash | 21.7M | 22.3M | 12.4M | (67.4M) | 5.1M | 5.4M | |
| Stock Based Compensation | 10.8M | 10.1M | (4.5M) | 17.6M | 2.7M | 2.6M | |
| Free Cash Flow | 32.4M | 51.1M | 15.6M | (25.1M) | 8.0M | 15.1M | |
| Change In Working Capital | (13.6M) | 15.3M | (13.3M) | (14.5M) | (3.2M) | (3.3M) | |
| Begin Period Cash Flow | 42.8M | 64.5M | 86.8M | 99.2M | 31.8M | 53.8M | |
| Other Cashflows From Financing Activities | 197.8M | 49.3M | (1.9M) | (3.4M) | (4.2M) | (4.0M) | |
| Depreciation | 30.3M | 28.6M | 34.9M | 66.8M | 57.4M | 40.8M | |
| Other Non Cash Items | 5.4M | 3.5M | 6.1M | 182.8M | 57.6M | 35.2M | |
| Capital Expenditures | 8.3M | 20.7M | 7.4M | 11.5M | 7.4M | 8.5M | |
| Total Cash From Operating Activities | 40.7M | 71.8M | 23.0M | (13.5M) | 15.3M | 19.5M | |
| Change To Account Receivables | (14.9M) | (3.9M) | (20.1M) | (18.0M) | 10.1M | 10.6M | |
| Net Income | 8.1M | 14.7M | 9.6M | (213.4M) | (96.7M) | (91.9M) | |
| Total Cash From Financing Activities | (11.0M) | (29.6M) | 273.4M | 62.1M | (26.7M) | (25.3M) | |
| End Period Cash Flow | 64.5M | 86.8M | 99.2M | 31.8M | 37.0M | 51.7M | |
| Dividends Paid | 9.1M | 19.9M | 367K | 3.4M | 3.0M | 5.5M | |
| Investments | (7.9M) | (20.5M) | (13.5M) | (116.4M) | 13.0M | 13.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.